BET bromodomain inhibitor HMBA synergizes with MEK inhibition in treatment of malignant glioma

Elisa Funck-Brentano, Dzeneta Vizlin-Hodzic, Jonas A Nilsson, Lisa M Nilsson

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'BET bromodomain inhibitor HMBA synergizes with MEK inhibition in treatment of malignant glioma'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology

Neuroscience